drugset / Trial / NCT04867369

Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis

NCT04867369 ↗

Phase 4 Completed 160 enrolled NYU Langone Health
RandomizedParallel-groupSingle-blindTreatment

Summary

A phase IV, randomized, single-blind, single-center study measuring the effects of Pecs II block with 0.25% bupivacaine versus surgeon infiltration with 0.25% bupivacaine on postoperative pain control and opioid utilization in participants who undergo open subpectoral tenodesis.

Timeline

Start
2021-07-14
Primary completion
2023-11-08
Completion
2023-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 15 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other

Indications